Quest Magazine

Retiree with BMD is the Best at Beauty Pageants

Beauty pageants are not events that just happen by themselves, as Will Isgett can attest.

He’s one of 42 local executive directors of preliminary beauty pageants in South Carolina cities that culminate every year in the Miss South Carolina pageant. In 2010, the Miss South Carolina Board of Directors voted him the best of the bunch, for the pageant he directed in his hometown of Darlington.

Study to Probe Oxidative Stress in People With ALS

More than 400 people who recently received an ALS diagnosis are being sought for a large study of a cell-damaging phenomenon called "oxidative stress," common in ALS and other degenerative diseases.

Oxidative stress is a type of damage that results from high levels of toxic byproducts of energy production inside cells. These toxic chemicals — known as free radicals — normally are present, but when they're produced in excess or when cells become unable to detoxify them, they become dangerous.

‘Power for the Journey’ Gives Back to ALS Community

When you’re hoping to earn $14, but wind up making $20 instead, that’s good reason to be happy.

Marlene Zaleski and four of her friends found themselves in just such a situation, except the $14 was $14,000, and the final tally from their ALS fundraising run/walk in Cookeville, Tenn., on April 24 was not $20 but $20,118. All proceeds from the event went to MDA’s Augie’s Quest ALS research effort.

Utah Researchers Seek CMD Families

Families affected by either of two forms of congenital muscular dystrophy (CMD), known as Ullrich CMD and Bethlem myopathy, are invited to help with an MDA-supported data collection project at the University of Utah in Salt Lake City. The project's investigators are seeking to correlate genetic and clinical (symptom-related) information to improve understanding of these diseases and begin to develop treatments.

About Ullrich CMD and Bethlem myopathy

Nonwalkers With SMA At High Risk for Weight Gain

Children and adults with types 2 and 3 spinal muscular atrophy (SMA) who are no longer walking have an increased risk of being overnourished and overweight if they otherwise have relatively good motor function, a multicenter study shows.

The results emphasize the importance of a "dedicated and experienced nutritionist" in SMA medical management, the researchers say.

About the study

Antisense Treatment Restores Full-Length SMN in SMA Mice

Scientists have found that mice with a disease resembling a mild form of spinal muscular atrophy (SMA) known as SMA type 3 showed more production of a needed protein in their spinal cords and more normal-looking ears and tails after treatment with a gene-modifying molecule that researchers hope could become a treatment for human SMA.

About the new findings

Disability Activist with SMA is a Globe Trotter

Life has been a whirlwind of activity for Victor Pineda lately.  The 31-year-old bachelor got married the first week in July.  He earns his Ph.D. in government planning around the first of August.

But these momentous events are almost insignificant compared to the rest of his typical schedule. In 2005 Pineda created the Victor Pineda Foundation (VPF) and today it commands most of his time.

Clothing Designers with MD: Striving for Sartorial Excellence

Four young men with powerful entrepreneurial spirits and a flair for design are making inroads in the country’s custom clothing industry. Although each of the three companies offers its own distinctive designs, the owner/operators have a lot in common.

Participants Sought for Three ALS Trials

Research scientists are seeking individuals interested in participating in any of the following three trials in ALS.

High-fat, high-calorie diets

Enrollment is open in an MDA-supported study comparing three tube-feeding formulas – one high in calories; one high in fat calories; and one standard formula – in people with ALS.

Lumizyme Now Commercially Available for Pompe

 Monique Griffin of Orlando, Fla., was one of the first in the nation to receive the commercially available treatment Lumizyme for acid maltase deficiency (AMD, or Pompe disease).

Pages